Glenmark Naproxen Sodium 550 mg Tablets Recalled for CGMP Deviations
Glenmark Pharmaceuticals is recalling specific lots of Naproxen Sodium 550 mg tablets nationwide due to manufacturing deviations. The firm initiated the voluntary recall on August 27, 2021.
- Product
- NAPROXEN SODIUM — NAPROXEN SODIUM (NAPROXEN SODIUM)
- Category
- Drug
- Distribution
- Distributed nationwide